Centene (CNC) Projected to Post Earnings on Wednesday

Centene (NYSE:CNC) is projected to release its Q3 2025 results before the market opens on Wednesday, October 29th. Analysts expect Centene to post earnings of ($0.18) per share and revenue of $47.5021 billion for the quarter. Parties can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Wednesday, October 29, 2025 at 9:00 AM ET.

Centene (NYSE:CNC) last announced its quarterly earnings results on Friday, July 25th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.39). The company had revenue of $48.74 billion for the quarter, compared to analysts’ expectations of $44.71 billion. Centene had a net margin of 1.15% and a return on equity of 9.57%. Centene’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.42 EPS. On average, analysts expect Centene to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Centene Stock Performance

Centene stock opened at $34.07 on Monday. Centene has a fifty-two week low of $25.08 and a fifty-two week high of $70.11. The stock has a market cap of $16.73 billion, a price-to-earnings ratio of 8.43, a PEG ratio of 1.34 and a beta of 0.48. The stock’s 50 day simple moving average is $33.01 and its two-hundred day simple moving average is $42.56. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10.

Analyst Ratings Changes

Several equities research analysts recently weighed in on CNC shares. JPMorgan Chase & Co. reduced their price target on Centene from $48.00 to $30.00 and set a “neutral” rating on the stock in a research note on Tuesday, July 29th. Mizuho increased their price target on shares of Centene from $28.00 to $40.00 and gave the stock a “neutral” rating in a research note on Thursday, October 9th. Cantor Fitzgerald restated a “neutral” rating and issued a $38.00 price objective on shares of Centene in a report on Tuesday, August 26th. Oppenheimer lowered their target price on shares of Centene from $51.00 to $43.00 and set an “outperform” rating for the company in a report on Monday, July 28th. Finally, TD Cowen reiterated a “hold” rating and set a $33.00 price objective (down previously from $73.00) on shares of Centene in a research note on Monday, July 21st. Three research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $39.50.

Insider Buying and Selling at Centene

In other Centene news, CEO Sarah London purchased 19,230 shares of the stock in a transaction dated Friday, August 8th. The shares were purchased at an average cost of $25.50 per share, with a total value of $490,365.00. Following the completion of the acquisition, the chief executive officer directly owned 845,275 shares in the company, valued at $21,554,512.50. This trade represents a 2.33% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 0.36% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Centene

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. MUFG Securities EMEA plc bought a new stake in shares of Centene in the second quarter worth approximately $79,000. Geneos Wealth Management Inc. boosted its holdings in Centene by 29.8% in the second quarter. Geneos Wealth Management Inc. now owns 1,897 shares of the company’s stock worth $103,000 after purchasing an additional 435 shares during the last quarter. Headlands Technologies LLC grew its position in Centene by 1,236.2% in the 2nd quarter. Headlands Technologies LLC now owns 3,247 shares of the company’s stock worth $176,000 after purchasing an additional 3,004 shares during the period. HUB Investment Partners LLC purchased a new stake in Centene during the 2nd quarter valued at $204,000. Finally, Baird Financial Group Inc. bought a new position in shares of Centene during the 1st quarter valued at $236,000. Institutional investors own 93.63% of the company’s stock.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.